Quoin Pharmaceuticals, Ltd. Annual Share-based Payment Arrangement, Expense in USD from 2021 to 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Quoin Pharmaceuticals, Ltd. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2021 to 2024.
  • Quoin Pharmaceuticals, Ltd. Share-based Payment Arrangement, Expense for the quarter ending December 31, 2024 was $328K, a 10.8% increase year-over-year.
  • Quoin Pharmaceuticals, Ltd. Share-based Payment Arrangement, Expense for the twelve months ending December 31, 2024 was $1.26M, a 15.6% increase year-over-year.
  • Quoin Pharmaceuticals, Ltd. annual Share-based Payment Arrangement, Expense for 2024 was $1.26M, a 15.6% increase from 2023.
  • Quoin Pharmaceuticals, Ltd. annual Share-based Payment Arrangement, Expense for 2023 was $1.09M, a 42.7% increase from 2022.
  • Quoin Pharmaceuticals, Ltd. annual Share-based Payment Arrangement, Expense for 2022 was $764K.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $1.26M +$170K +15.6% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-13
2023 $1.09M +$326K +42.7% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-13
2022 $764K +$764K Jan 1, 2022 Dec 31, 2022 10-K 2024-03-14
2021 $0 Jan 1, 2021 Dec 31, 2021 10-K 2023-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.